Literature DB >> 8500564

Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse.

H S Lazarus1, W S Sly, J W Kyle, G S Hageman.   

Abstract

Recent studies suggest that chondroitin sulfate proteoglycans in the retinal interphotoreceptor matrix (IPM) play a role in maintaining photoreceptor viability. We report herein studies on the retinas from mice with mucopolysaccharidosis type VII (MPS VII), a storage disorder resulting from virtual absence of beta-glucuronidase, an enzyme that is involved in the lysosomal degradation of chondroitin sulfate and other beta-glucuronide-containing proteoglycans. The distribution of IPM chondroitin sulfate proteoglycans was examined by immunohistochemistry and lectin-based histochemistry, and compared with the morphology of photoreceptor and retinal pigmented epithelial (RPE) cells at various ages in MPS VII-affected mice. A number of lectins and antibodies were employed that react with epitopes of IPM chondroitin sulfate proteoglycans, including Triticum vulgaris agglutinin (WGA), Arachis hypogaea agglutinin (PNA), Phaseolus vulgaris agglutinin (PHA-L), and an antibody directed against chondroitin 6-sulfate (AC6S). In MPS VII-affected animals, slight shortening of photoreceptor outer segments occurs between postnatal months 1 and 8. This is associated with changes in the distribution of some of the IPM chondroitin sulfate proteoglycans and hypertrophy of the retinal pigmented epithelium due to the accumulation of cytoplasmic membrane-bounded vesicles. WGA- and PHA-L-, but not AC6S-binding glycoconjugates accumulate within the RPE of affected mice during this time. Immunoreactive chondroitin 6-sulfate is not observed within the RPE of affected animals, probably since the antibody employed does not label free chondroitin sulfate glycosaminoglycan fragments. A loss of the normal apical-basal distribution of chondroitin 6-sulfate and PHA-L-binding IPM proteoglycans is apparent by 4 postnatal months. In contrast, WGA-binding proteoglycan remains uniformly distributed through 8 months. Pyknotic photoreceptor nuclei are observed in months 2-5 and photoreceptor loss is observed by 6 months. Cone photoreceptor loss appears to occur prior to that of rod photoreceptors. These observations suggest that the absence of beta-glucuronidase in the RPE of MPS VII mice may lead to an altered distribution of at least some IPM chondroitin sulfate proteoglycans. The resultant changes in the biochemical composition and/or physical structure of the IPM may affect subsequently its photoreceptor cell-supportive function leading to photoreceptor degeneration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500564     DOI: 10.1006/exer.1993.1067

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Comparative pathology of murine mucolipidosis types II and IIIC.

Authors:  P Vogel; B J Payne; R Read; W-S Lee; C M Gelfman; S Kornfeld
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

2.  Response to: spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, IV A, and VI.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-24       Impact factor: 3.117

3.  Differential binding to glycotopes among the layers of three mammalian retinal neurons by man-containing N-linked glycan, T(alpha) (Galbeta1-3GalNAcalpha1-), Tn (GalNAcalpha1-Ser/Thr) and I (beta)/II (beta) (Galbeta1-3/4GlcNAcbeta-) reactive lectins.

Authors:  Wei-Chi Wu; Chi-Chun Lai; Jia-Hau Liu; Tanuja Singh; Lien-Ming Li; Willy J Peumans; Els J M Van Damme; Albert M Wu
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

4.  Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.

Authors:  Andrew I Brooks; Colleen S Stein; Stephanie M Hughes; Jason Heth; Paul M McCray; Sybille L Sauter; Julie C Johnston; Deborah A Cory-Slechta; Howard J Federoff; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

Review 6.  Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.

Authors:  C Vogler; M S Sands; N Galvin; B Levy; C Thorpe; J Barker; W S Sly
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

7.  Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.

Authors:  T Li; B L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies.

Authors:  Augusto Magalhães; Ana Maria Cunha; Rodrigo Vilares-Morgado; Elisa Leão-Teles; Esmeralda Rodrigues; Manuel Falcão; Ângela Carneiro; Jorge Breda; Fernando Falcão-Reis
Journal:  Case Rep Ophthalmol Med       Date:  2021-04-12

9.  Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.

Authors:  A Donsante; B Levy; C Vogler; M S Sands
Journal:  J Inherit Metab Dis       Date:  2007-02-16       Impact factor: 4.750

Review 10.  Electrophysiological analysis of visual function in mutant mice.

Authors:  Neal S Peachey; Sherry L Ball
Journal:  Doc Ophthalmol       Date:  2003-07       Impact factor: 1.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.